Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study-Reference-Cited by-同舟云学术

Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study

Author:

Marsden J.R.¹,Fox R.²,Boota N.M.³,Cook M.⁴,Wheatley K.²,Billingham L.J.²,Steven N.M.²,

Affiliation:

1. University Hospitals Birmingham NHS Foundation Trust; Queen Elizabeth Hospital; Edgbaston Birmingham B15 2TH U.K.

2. Cancer Research U.K. Clinical Trials Unit; School of Cancer Sciences; The University of Birmingham; Edgbaston Birmingham B15 2TT U.K.

3. Nottingham Clinical Trials Unit; University of Nottingham; Nottingham U.K.

4. Royal Surrey County Hospital; Guildford U.K.

Funder

National Institute for Health Research

Research for Patient Benefit Programme

National Health Service

Department of Health

Publisher

Wiley

Subject

Dermatology

Link

Reference27 articles.

4. Surgical treatment of lentigo maligna using 2-mm excision margins;Preston;Br J Dermatol,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Lentigo maligna: a review;Clinical and Experimental Dermatology;2023-11-15

4. Back to Basics;Journal of the Dermatology Nurses' Association;2023-08-24